ILS Course



Unfortunately, due to the restrictions on group gatherings and advice on social distancing, we have had to cancel our planned ILS courses on 27th March and 3rd April 2020.

We understand that this is far from ideal, and not a decision taken lightly, but a necessary one to play our part in the control of COVID-19.

We hope to continue our courses from 28th April, however this may be subject to change. If you have any concerns or queries, please email courses@richmondpharmacology.com

These courses will equip external healthcare professionals with the skills to assist patients in preventing or treating cardiac arrest. Richmond Pharmacology will offer an E-ILS (£80) and Full ILS Course (£120).

Registration Form

Full ILS Course 2019


1. Thursday 12th December 2019 09:00-16:00

Full ILS Course 2020


1. Tuesday 14th January 2020 09:00-16:00
2. Thursday 30thJanuary 2020 09:00-16:00
3. Tuesday 18th February 2020 09:00-16:00
4. Tuesday 25th February 2020 09:00-16:00
5. Tuesday 10th March 2020 09:00-16:00
6. Friday 27th March 2020 09:00-16:00
7. Friday 3rd April 2020 09:00-16:00
8. Tuesday 28th April 2020 09:00-16:00
9. Thursday 14th May 2020 09:00-16:00
10. Wednesday 27th May 2020 09:00-16:00
11. Friday 12th June 2020 09:00-16:00
12. Tuesday 23rd June 2020 09:00-16:00

To find out more information on the ILS Training, please email us: courses@richmondpharmacology.com

Additionally, to find out more about the ILS training courses offered by the Resuscitation Council (UK), please check here.

Courses will be held:

St John Ambulance London Bridge
Lyon House
160-166 Borough High Street
London
SE1 1LB

check it



Testimonials

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

First transdermal patch to treat schizophrenia hits market

18th Mar 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia

Read more ›

Richmond Pharmacology supporting clinical facilities in Nicaragua

30th Jan 2020

Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site

Read more ›

Cardiac Safety London

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts

View event ›